BV is prescribed in adults for the treatment of Hodgkin lymphoma (HL), CD30+ HL, systemic anaplastic large cell lymphoma, and cutaneous T-cell lymphoma [40,41,42]. This evidence concerns the gene TNFRSF8 and Hodgkins lymphoma.